Daily as of 3 Nov 16:00 ET
- Price
- below both $5.74 vs 50 $7.52 / 200 $10.35
- Projection
- No cross projected
- Test
- No active test
- Last cross
- ๐Death cross 26 Mar 2026 ยท projected 29 bars out ยท tested 1 bar
Phathom Pharmaceuticals (PHAT) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2021.
The 50 SMA has sat below the 200 on the daily since Mar 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits below the 50 and the 200 on the daily, the weekly and the 4-hour. On the weekly a death cross is projected within 10 bars.
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 26 Mar 2026 | ๐Death steep | daily | 29 bars out | 1 bar cross test |
| week of 16 Feb 2026 | ๐จGolden moderate | weekly | 26 bars out | 7 bar cross test |
| 12 Feb 2026 | ๐Death | 4-hour | 29 bars out | Not tested |
| 30 Jul 2025 | ๐จGolden steep | daily | 30 bars out | 2 bar cross test |
| 13 Jun 2025 | ๐จGolden | 4-hour | 11 bars out | โ |
Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.